Search

Your search keyword '"Jang, Myoung Ho"' showing total 233 results

Search Constraints

Start Over You searched for: Author "Jang, Myoung Ho" Remove constraint Author: "Jang, Myoung Ho"
233 results on '"Jang, Myoung Ho"'

Search Results

3. Combined IgE neutralization and Bifidobacterium longum supplementation reduces the allergic response in models of food allergy

4. Preventive and Therapeutic Effects of Lactiplantibacillus plantarum HD02 and MD159 through Mast Cell Degranulation Inhibition in Mouse Models of Atopic Dermatitis.

5. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of YH35324, a Novel Long-Acting High-Affinity IgETrap-Fc Fusion Protein, in Atopic Subjects with a Total IgE > 700 IU/mL

7. 710 Keynote-B59: dose escalation of a phase 1/2 first-in-human, open-label study of GI-101, a novel immunocytokine combining CD80-IL2v, in combination with pembrolizumab in advanced solid tumors

8. 1072 GI-108, a novel bispecific fusion protein augments anti-tumor immunity by alleviating immunosuppressive adenosine pathway in CD8+T cells

9. 729 A first-in-human, open-label, multicenter, phase 1/2a, dose escalation and expansion study of GI-102, a novel immunocytokine combining CD80-IL2v3, in patients with advanced or metastatic solid tumors

11. Intestinal Villous M Cells: An Antigen Entry Site in the Mucosal Epithelium

13. 718 Preliminary results of GII-101-P101 (Keynote-B59): GI-101 (CD80-IgG4 Fc-IL2v) as a single agent and in combination with pembrolizumab in patients with advanced and/or metastatic solid tumors

15. Degranulation of Mast Cells as a Target for Drug Development.

17. 470 A phase 1/2, open-label, dose escalation and expansion study of GI-101 as a single agent and in combination with a pembrolizumab, lenvatinib or local RT in advanced solid tumors (KEYNOTE-B59)

20. Abstract 1826: Comprehensive preclinical study on GI-101, a novel CD80-IgG4-IL2 variant protein, as a therapeutic antibody candidate with bispecific immuno-oncology target

21. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1β production

23. Double-Stranded RNA of Intestinal Commensal but Not Pathogenic Bacteria Triggers Production of Protective Interferon-β

24. Abstract 6529: GI101, A novel CD80-IgG4-IL2 variant bispecific protein, inhibits tumor growth and induces anti-tumor immune response in multiple preclinical models

25. Cancer Therapy: Harnessing the Formation of Natural Killer–Tumor Cell Immunological Synapses for Enhanced Therapeutic Effect in Solid Tumors (Adv. Mater. 22/2020)

31. Two-photon microscopy of Paneth cells in the small intestine of live mice

33. Moxifloxacin: Clinically compatible contrast agent for multiphoton imaging

35. Gut-Specific Delivery of T-Helper 17 Cells Reduces Obesity and Insulin Resistance in Mice

38. Moxifloxacin: Clinically compatible contrast agent for multiphoton imaging

39. SH2 Domains Serve as Lipid-Binding Modules for pTyr-Signaling Proteins

40. Small intestinal eosinophils regulate Th17 cells by producing IL-1 receptor antagonist

46. Oral immunization of haemaggulutinin H5 expressed in plant endoplasmic reticulum with adjuvant saponin protects mice against highly pathogenic avian influenza A virus infection

49. Ulmus davidiana var. japonica Nakai Upregulates Eosinophils and Suppresses Th1 and Th17 Cells in the Small Intestine

Catalog

Books, media, physical & digital resources